Biora Therapeutics (BIOR) Set to Announce Earnings on Monday

Biora Therapeutics (NASDAQ:BIOR) is set to release its earnings data after the market closes on Monday, August 12th. Analysts expect Biora Therapeutics to post earnings of ($0.45) per share for the quarter.

Biora Therapeutics (NASDAQ:BIOR) last announced its earnings results on Wednesday, May 15th. The company reported ($0.61) EPS for the quarter, missing analysts’ consensus estimates of ($0.45) by ($0.16). The business had revenue of $0.54 million for the quarter. On average, analysts expect Biora Therapeutics to post $-2 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Biora Therapeutics Stock Down 0.0 %

Shares of BIOR traded down $0.00 during mid-day trading on Friday, hitting $0.59. 9,793 shares of the company traded hands, compared to its average volume of 342,950. Biora Therapeutics has a 1-year low of $0.48 and a 1-year high of $3.65. The company has a market capitalization of $21.13 million, a PE ratio of -0.08 and a beta of 1.23. The business has a 50 day moving average of $0.67 and a 200 day moving average of $0.80.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright reiterated a “buy” rating and issued a $15.00 target price on shares of Biora Therapeutics in a research report on Monday, July 22nd.

Biora Therapeutics Company Profile

Biora Therapeutics, Inc, a clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States. The company offers NaviCap, a targeted oral delivery platform for delivery of therapeutics in the gastrointestinal tract to enhance the treatment of inflammatory bowel diseases; and BioJet, a systemic oral delivery platform designs to replace injection with needle-free, oral delivery of large molecules for management of chronic diseases.